The DOI matches its Crossref record; 34 of the 38 references it cites were found in a registry or an index.
Preclinical Development of Nononcogenic Drugs (Small and Large Molecules)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Irwin, S. (1968) · Psychopharmacology · doi:10.1007/bf00401402 · Cited by 1,240
Drug Metabolites in Safety Testing
Baillie, T. A. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9440 · Cited by 371
Preclinical safety evaluation of biotechnology-derived pharmaceuticals
Cavagnaro, J. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd822 · Cited by 340
Species differences in the structure and function of the immune system
Haley, P. J. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00043-x · Cited by 336
Faed, E. M. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409033562 · Cited by 299
(2009) · CRC Press eBooks · doi:10.3109/9781420081275-20 · Cited by 163
Timsit, J., Savino, W., Safieh‐Garabedian, B., Chanson, P., Gagnerault, M., Bach, J., & Dardenne, M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1619008 · Cited by 155
Dissolution Testing of Semisolid Dosage Forms
(2009) · CRC Press eBooks · doi:10.3109/9781420081275-21 · Cited by 128
Preclinical safety testing of monoclonal antibodies: the significance of species relevance
Chapman, K., Pullen, N., Graham, M., & Ragan, I. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2242 · Cited by 121
A Performance Standard for Clinical and Functional Observational Battery Examinations of Rats
Mattsson, J. L., Spencer, P. J., & Albee, R. R. (1996) · Journal of the American College of Toxicology · doi:10.3109/10915819609008716 · Cited by 117
Cited by
Sorted by citations
Emerging issues in probiotic safety: 2023 perspectives
Merenstein, D., Pot, B., Leyer, G., Ouwehand, A. C., Preidis, G. A., Elkins, C. A., Hill, C., Lewis, Z. T., Shane, A. L., Zmora, N., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185034 · Cited by 481
Preclinical Formulations: Insight, Strategies, and Practical Considerations
Shah, S. M., Jain, A. S., Kaushik, R., Nagarsenker, M. S., & Nerurkar, M. J. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0156-1 · Cited by 80
Das, S., Das, M. K., Jamatia, T., Bhattacharya, B., Mazumder, R., Yadav, P. K., Bishwas, N. R. G., Deka, T., Roy, D., Sinha, B., et al. (2024) · RSC Pharmaceutics · doi:10.1039/d3pm00008g · Cited by 38
Psidium guajava L.: From byproduct and use in traditional Mexican medicine to antimicrobial agent
Gutierrez-Montiel, D., Guerrero-Barrera, A. L., Vela, N. A. C., Avelar-González, F. J., & García, I. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1108306 · Cited by 34
Mazumder, K., Sumi, T. S., Golder, M., Biswas, B., Maknoon, & Kerr, P. G. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113781 · Cited by 26
Clove (Syzygium aromaticum) and eugenol toxicity
Özbek, Z. A., & Ergönül, P. G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85177-0.00029-x · Cited by 16
Japan-Specific Key Regulatory Aspects for Development of New Biopharmaceutical Drug Products
Desai, K. G. H., Obayashi, H., Colandene, J. D., & Nesta, D. P. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.03.017 · Cited by 14
Kamil, M. R., Fatima, A., Ullah, S., Ali, G., Khan, R., Ismail, N., Qayum, M., Irimie, M., Dinu, C. G., Ahmedah, H. T., et al. (2021) · Toxics · doi:10.3390/toxics9060119 · Cited by 13
Enyoh, C. E., Maduka, T. O., Wang, Q., & Islam, M. R. (2022) · ACS Food Science & Technology · doi:10.1021/acsfoodscitech.2c00217 · Cited by 13
Good Laboratory Practice (GLP) Requirements for Preclinical Animal Studies
Srinivasan, K., Tikoo, K., & Jena, G. (2021) · Springer eBooks · doi:10.1007/978-981-16-0987-9_27 · Cited by 8
Dermatological Delivery of Nanodrugs
Shivalkar, S., Verma, A., Singh, V. K., & Sahoo, A. K. (2021) · doi:10.1002/9781119769897.ch12 · Cited by 6
Regulatory toxicology testing for pharmaceuticals
Kuppasani, P. R., & Thomas, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00021-2 · Cited by 4
Sajak, A. A. B., Azlan, A., Abas, F., & Hamzah, H. B. (2020) · Food Research · doi:10.26656/fr.2017.4(s1).s11 · Cited by 4
Examining the Toxicological Landscape of New Molecular Entities and Biotherapeutics
Narayanan, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-81787-8_10 · Cited by 3
Regulatory issues in biological products
Sangeetha, V. P., Remya, N. S., & Mohanan, P. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823966-7.00005-0 · Cited by 3
Kumar, S., Sharma, N., Dantas, W. M., do Nascimento, J. C. F., Maus, H., de Oliveira, R. N., Pandit, U. P., Singh, A. P., Schirmeister, T., Hazari, P. P., et al. (2022) · New Journal of Chemistry · doi:10.1039/d2nj02482a · Cited by 3
Understanding pharmacotoxicology
Pawar, B., Gupta, T., Vasdev, N., Tekade, M., Arafat, B. T., & Tekade, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15840-7.00025-7 · Cited by 3
Toxicity Assessment of Ethanol Extract of Lygodium microphyllum
Kuncoro, H., Tappi, A. S. A. M., & Anggreini, P. (2024) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v8i7.20 · Cited by 3
Sulaiman, C. T., Jyothi, C. K., Jinu Krishnan Unnithan, G., Prabhukumar, K. M., & Balachandran, I. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100085 · Cited by 3
Yadav, C. K., Sandhya, K. C., Thapa, S., Kandel, K., Shrestha, L., Palikhey, A., & Lamsal, A. (2023) · Preprints.org · doi:10.20944/preprints202307.1457.v1 · Cited by 3
Yadav, C. K., Sandhya, K. C., & Thapa, S. (2024) · Global Advances in Integrative Medicine and Health · doi:10.1177/27536130241270621 · Cited by 2
Human Toxicity of Nanoinsecticides
Farhat, S. K., Binduja, S., & Krishnan, J. (2024) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-75798-3_9 · Cited by 2
Drug discovery: Chaos can be your friend or your enemy
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00012-2 · Cited by 3
Lahiani, A., Haham, D., Lankri, D., Cornell-Kennon, S., Schaefer, E., Tsvelikhovsky, D., & Lazarovici, P. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00255 · Cited by 2
Acute toxicity of C60–Cis-Pt nanocomplex in vivo
Lynchak, O. V., Byelinska, I. V., Dziubenko, N., Kuznietsova, H. M., Abramchuk, O., & Prylutska, S. (2021) · Applied Nanoscience · doi:10.1007/s13204-021-01680-3 · Cited by 2
Nazifi, A. B., Abubakar, A., Magaji, M. G., Aliyu, M., Yaro, A. H., & DANJUMA, N. M. (2023) · Journal of Pharmacy & Bioresources · doi:10.4314/jpb.v20i3.6 · Cited by 2
Mane, V. B., Killedar, S. G., & More, H. N. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns8.11579 · Cited by 1
Hidayat, T., Samsudin, M., & Musoddaq, M. A. (2022) · Media Gizi Mikro Indonesia · doi:10.22435/mgmi.v14i1.6022 · Cited by 1
Toxicity Profiling and Antihyperuricemic Activity of Goubion: A Polyherbal Formulation
Sadia, H., Naveed, S., Rehman, H., Usman, R., Qamar, F., Yasmeen, S., Sana, A., Mughal, M., Asif, S., & Razzaq, G. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/7088628 · Cited by 1
Kumar, M., Kaushik, D., Kaushik, R., Khan, A. U., Billeci, L., Öz, E., Proestos, C., Brennan, C. S., Ahmad, N., Elobeid, T., et al. (2023) · International Journal of Food Science & Technology · doi:10.1111/ijfs.16669 · Cited by 1
Shailaja, A. D., & Pramodkumar, J. S. (2023) · International Journal of Pharmaceutical Quality Assurance · doi:10.25258/ijpqa.14.4.34 · Cited by 1
Role of Metabolism in Drug Toxicity
Coleman, M. D. (2020) · Wiley eBooks · doi:10.1002/9781119658016.ch8 · Cited by 1
Drugs From Threatened Medicinal Plants
Das, K., & Rajasekharan, P. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-39793-7_12
Askari, P., & Hosseini, M. (2020) · Pharmaceutical Sciences · doi:10.34172/ps.2020.87
Karasulu, H. Y., Al, A. M., Diril, M., Kunt, Ş. T., Kozlu, S., & Topcu, E. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4597971
Amoateng, E. O., Amoateng, P., Ossei, P. P. S., Fenteng, E. A., Amponsah, I. K., Ayibor, W. G., Adjei, S., & Narh-Bedu, T. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4628100
Salawu, O. A., Micah, P. W., Ibrahim, H., Mohammed, A. S., Isaac, R. E., & Oladepo, O. M. (2025) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-025-00847-5
Metadata
- Authors
- Colerangle, J. B.
- Corresponding author
- Colerangle, J.B.
- Venue
- A Comprehensive Guide to Toxicology in Nonclinical Drug Development
- Publisher
- Elsevier
- Published
- 2017
- Pages
- 659-683
- OpenAlex
- W2488067649
- Cited by
- 37
- References
- 38
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 11 · 2022: 6 · 2021: 5 · 2020: 5 · 2018: 1
- FWCI
- 0.74
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Elsevier eBooks (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- preclinical drug development, biopharmaceuticals, pharmaceuticals, lead candidate selection, formulation development, route of administration, pharmacokinetics, toxicity prediction, animal species selection, epitope expression, therapeutic index, good laboratory practice, ICH guidelines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review